PTC Therapeutics Provides a Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. ACN
3. NVDA
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. HOOD
10. MSFT

Go back to PTC Therapeutics Provides a Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results

PTC Therapeutics (PTCT) Misses Q4 EPS by 78c; Offers FY23 Guidance

February 21, 2023 4:24 PM EST

PTC Therapeutics (NASDAQ: PTCT) reported Q4 EPS of ($2.35), $0.78 worse than the analyst estimate of ($1.57). Revenue for the quarter came in at $167.4 million versus the consensus estimate of $190.38 million.

GUIDANCE:

PTC Therapeutics sees FY2023 revenue of $0.94-1 billion, versus the... More